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Background: Two-photon polymerization, optionally combined with stimulated emission depletion (STED)
lithography, allows two and three dimensional polymer fabrication with structure sizes and resolution below the
diffraction limit. Structuring of polymers with photons, whose wavelength is within the visible range of the
electromagnetic spectrum, gives new opportunities to a large field of applications e.g. in the field of biotechnology
and tissue engineering. In order to create new biotechnological applications, versatile methods are needed to
functionalize the polymeric structures.
Results: Here we report the creation of polymer-nanodots with high streptavidin (SA) affinity via two-photon
polymerization (TPP). Controlling the size of the polymer dots allows for limiting the number of the SA molecules.
TPP dots with a diameter of a few 100 nm show up to 100% streptavidin loading. We can show that most of the
dots are loaded by one to two streptavidins on average. Attached streptavidin molecules remain functional and are
capable to bind 0.7 biotin molecules on average.
Conclusion: The presented functionalized nanostructures may be used as platforms for a multitude of biological
experimental setups. Nanoscopic well defined structures, capable of selective binding of streptavin proteins, used as
linkers for other biotinylated biomolecules, may also find application in in-vitro sensing, like for example lab on chip
devices with limited surface area.
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In 1997, Kawata and his group employed visible light for
three-dimensional two-photon-induced lithography [1].
Nowadays, two-photon polymerization (TPP) is used to
write features with lateral sizes of 90 [2], 80 [3,4], and
65 nm [5] using pulsed lasers for two-photon excitation
with wavelengths of 1030, 800 and 520 nm, respectively.
Recently, STED- and STED-inspired diffraction-
unlimited lithography has been realized [6-10]. In STED-
lithography [11], one laser pulse excites photoinitiators for
radical polymerization and a second laser locally inhibits
the ability of the photoinitiator to start the polymerization
in the outer rim of the excitation point spread function
(PSF). Thereby, polymerization is restricted to the inner
part of the PSF, thus creating a shrunken “effective PSF”.* Correspondence: jaroslaw.jacak@jku.at
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unless otherwise stated.Such a STED-based approach allows the generation of
structures with feature sizes below the limits of TPP. Cur-
rently, feature sizes as small as 55 nm and a resolution of
120 nm can be achieved [12].
Mixing of different acrylate precursors allows for tun-
ing the polymer properties such as mechanical stiffness,
surface charge and surface energy which in turn can
tune the degree of hydrophobicity or improve protein
adhesion [13,14]. Applying STED–lithography, we were
able to show that single antibodies can be attached to
quasi 0-dimensional polymer dots, the so called ‘nanoan-
chors’ [15]. The engineering of protein nanoarrays is of
great importance for medical and biological applications,
including biosensors and drug screening. Protein nano-
patterns with tunable features can for example be used
to mimic an in vivo-like environment in order to pre-
cisely manipulate the behavior of living cells to analyze
the interaction between the cells and matrix [16-20].
The goal of this work was to establish a highly versatile
method for conjugating nanoscopic polymer structuresentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of the structured polymer [15], it is well suited for the use
of the streptavidin/biotin crosslinking system, a commonly
used protein-based linker system for coupling of molecules
[20-24]. The streptavidin/biotin binding belongs to the
strongest non-covalent interactions (Ks ~ 10
13 M−1) known
in biology [21]. Biotin-associated hetero-bifunctional linkers
with reactive chemical groups or even macromolecules are
widely accessible [25]. In order to characterize the streptavi-
din adhesion to two-photon nanostructured dots, we varied
the dot size, the substrate properties and the concentration
of fluorescently labeled streptavidin and biotin during incu-
bation. Figure 1a shows a zoomed scanning electron mi-
croscopy (SEM) image of a TPP fabricated nanodot array.
In a second step, the dots are loaded (Figure 1d) with
streptavidin (labeled with Alexa555 in this case, Figure 1b).
Subsequently we add biotin which specifically binds to
streptavidin (labeled with Atto655, Figure 1c).
Results
Lithography of polymer nanodots
Structured nanodots of various sizes were fabricated
using TPP or STED-lithography. Polymer ‘nanoanchors’
with sizes as small as 65 nm in diameter can be achieved
using STED–lithography [15]. The TPP fabricated dots
described in this paper are up to ~300 nm in diameter.Figure 1 Incubation of nanodots. a) SEM image of TPP fabricated nanodot
photoinitiator. b) Nanodots incubated with Alexa555-streptavidin (@ 532 nm ex
incubation (@647 nm excitation). All images were taken with 10 ms illumination
time interval. d) A sketch of the incubation process for the nanodots. First phos
incubation, the slide is washed with PBS and Alexa555-streptavidin dilution is ad
Atto655-biotin diluted in PBS.We use a (80/20) mixture of the two acrylate monomers
SR499 (Sartomer, Colombes Cedex, France) and pentaery-
thritol triacrylate (PETA, Sigma-Aldrich, Vienna, Austria)
including 300-400 ppm monomethyl ether hydroquinone
with either 0.25 wt% 7-diethylamino-3-thenoylcoumarin
(DETC, Acros Organics, Geel, Belgium) as a depletable
photoinitiator [26] for STED-TPP or Irgacure 819
(BASF, Ludwigshafen, Germany), an efficient and non-
fluorescent photosensitive initiator for ordinary TPP.
This photoresist was shown in a previous study to have
antibody affinity [15]. For fabrication of nanodots with a
diameter of ~70 nm (surface areas < 104 nm2), we used
STED-lithography with 5.5 mW excitation and 28.8 mW
depletion power. Without depletion beam, two-photon ex-
citation powers between 5.5 and 6.5 mW are applied to
create nanodots with surface areas of 1-2 × 104 nm2, 1-2 ×
105 nm2 and > 2 × 105 nm2. Hence, dots of four different
sizes are written. They are arranged in arrays of 30 × 30 or
40 × 40 dots with 2 μm dot spacing each. Figure 2 shows a
schematic drawing of four arrays of nanodots with various
sizes and various streptavidin loading. The smallest dots,
shown in Figure 2a, are fabricated with STED-lithography
and show the lowest loading with streptavidin (~10% only,
vide infra). TPP fabricated dots have a size dependent
streptavidin loading reaching up to 100% for the largest
dots (sketched in Figure 2d).s with a surface area of 1×105-2×105 nm2, polymerized with Irgacure 819
citation). c) Nanodots with streptavidin after additional Atto655-biotin
time, no Irgacure 819 autofluorescence was detected for such a short
phate buffered saline (PBS) solution with lipid vesicles is added. After the
ded. Subsequently after an additional PBS washing step, we add
Figure 2 Schematic drawing of nanostructured dots. a) Sketch of nanostructured dots (nanoanchors) fabricated via STED-lithography and
incubated with fluorescent streptavidin. Only 10% of all dots were covered with proteins. b) Sketch of TPP fabricated dots having ~30% average
streptavidin loading per dot. c) and d) are sketches of the largest fabricated dots with over 80% and 100% streptavidin coverage.
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(Figure 1a) and fluorescence microscopy using an exci-
tation wavelength of 492 nm. The STED-lithography
fabricated dots contain DETC and are hence visible
due to their intrinsic fluorescence with an emission
maximum at 525 nm. Irgacure 819 exhibits only a very
weak broadband fluorescence when excited with
492 nm and 532 nm light. Depending on the photo-
initiator, we can either use red fluorophores for label-
ing (Atto655 (Atto-tec GmbH, Siegen, Deutschland)) on
the DETC containing STED-lithography fabricated dots,
or use green and red fluorophores for labeling (e.g.
Alexa555 and Atto655) when TPP with Irgacure 819 is
performed. The low autofluorescence of Irgacure 819 does
not disturb the quantitative signal analysis.
The streptavidin is either labeled with Atto655 or
Alexa555 fluorophores (see Materials: Labeling of Strep-
tavidin). For incubation, the streptavidin is dissolved in
phosphate buffered saline (PBS) (Sigma-Aldrich, Vienna,
Austria) and dropcast on to the samples. To avoid un-
specific streptavidin binding to the substrate, we use two
different coating strategies, either 5000-PEG-silane or a
supported lipid bilayer [27] for glass surface passivation.
For the first strategy, we coat the surface with PEG,
which is known to reduce protein adsorption due to its
hydrophilic nature [28,29], prior to writing the polymer
dots. For the second strategy, the dots are written on a
bare glass and subsequently, a bilayer coating is formed by
spreading of palmitoyloleoylphosphatidylcholine (POPC)
lipid vesicles [30]. The main advantage of lipid passivation
is the short incubation time, high bilayer homogeneity and
the ability of self-recovery. However, bilayer formation
only works in physiological buffers. In comparison, passiv-
ation with PEG is less dependent on environmental factors
but more vulnerable to surface defects [31,32].
Fluorescence images are taken after incubation of the
STED-lithographically fabricated nanoanchors or the
TPP dot arrays with Atto655 or Alexa555 labeled strep-
tavidin, respectively. We performed a stepwise increase
of the amount of streptavidin (2 μl of the stock solution
per 5 min incubation-step each) until the nanodots
are saturated.Figure 3a shows an image of Atto655 labeled streptavi-
din loosely attached to a lipid-coated glass slide. Since a
lipid supported bilayer exhibits strong repulsive forces
against proteins [27], we used high concentrations of
streptavidin without washing of the sample to introduce
at least some unspecific binding. High probability to find
single streptavidin on the lipid coated glass is used to
quantify the fluorescence strength of single streptavidin
in order to achieve a statistic of single molecule emission
strength shown in Figure 3c (red histogram).
Single molecule fluorescence microscopy is used to
analyze the streptavidin loading of the polymer nanodots.
For an estimation of the loading rates, the fluorescence
signal from occupied nanodots (Figure 3b) is compared
with signals of single streptavidin molecules sparsely dis-
tributed on lipid passivated glass (Figure 3a). To quantify
the fluorescence signals of the single streptavidin mole-
cules on glass as well as streptavidin incubated nanodots,
isotropic undecimated wavelet transformation [33] is used
for the recognition of individual fluorescent spots [34].
Further parameterization of the fluorescence signals is
performed by Gaussian fitting.
The Atto655 labeled streptavidin molecules which were
bound to the nanodots are shown in Figure 3b. Due to the
PEG passivation, almost no unspecific binding of the
streptavidin is observed after washing. The distribution of
fluorescence counts from nanodots loaded with streptavi-
din is shown in Figure 3c (blue histogram, > 500 single
molecule signals). The intensity distributions of streptavi-
din on lipid passivated glass (red) and on nanodots (blue)
differ, which indicates that quite a number of dots have
more than one SA molecule attached.
Streptavidin loading of nanodots
We find that only ~10% of all STED-lithographically fabri-
cated nanoanchors with ~70 nm average diameter (surface
areas <104 nm2) are loaded with at least one streptavidin.
This result was rather unexpected since we were able to
load 98% of STED-lithographically fabricated nanoanchors
with antibodies in a previous study [15]; i.e. the affinity of
proteins to nanoanchors seems to strongly depend on the
specific type of protein. Since only ~10% of all patches
Figure 3 Intensity distributions of Atto655-Streptavidin single molecules. Comparison of the single molecule Atto655-streptavidin signal on
glass and on 1 × 105-2 × 105 nm2 nanodots. a) Image of sparsely and randomly distributed Atto655-labeled streptavidin on a substrate without
acrylic patches passivated by lipids at 647 nm excitation (unwashed). b) Fluorescence after incubation of the TPP nanodots with Atto655-labeled
streptavidin, after washing (647 nm excitation). Over 80% of all dots carry at least one streptavidin. c) Statistical distribution of fluorescence intensity
counts per fluorescent spot during 10 ms illumination time, obtained from: (red) sparsely and randomly distributed streptavidin as shown in a) and
(blue) from nanodots loaded with streptavidin (see b).
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lithographically fabricated nanoanchors were not consid-
ered for further analysis.
In order to achieve a more detailed characterization of
the streptavidin binding properties, TPP nanodots with
different surface areas are polymerized. We classified the
dot area into three groups; the first groups surface area
is ~2 × 104 nm2, the second group covers around 1 ×
105-2 × 105 nm2, and the third category comprises areas
above 2 × 105 nm2. The dot area was approximated by a
spheroid which was parameterized by atomic force mi-
croscopy. These area classes correspond roughly to dots
with diameters of <150 nm, 200–300 nm and slightly
>300 nm, respectively. The nanodot surface is not only
given by the diameter of the nanodot, but also by the
nanodots height. This height can be adjusted by posi-
tioning the excitation point spread function axially with
~15 nm precision.
Figure 4 shows the loading of TPP nanodots with
Atto655-streptavidin with respect to the three nanodot
surface areas and for lipid (Figure 4a) or PEG (Figure 4b)
passivated sample surfaces. For instance, in case of the
PEG passivated TPP nanodots with surface areas of <2 ×
104 nm2, only 40 ± 9% of all dots carry at least one strepta-
vidin molecule. These 40 ± 9% of SA carrying dots carry
on average one streptavidin complex (1.3 = σ+; 0.96 = σ−).
In case of the lipid bilayer passivated surface, 28±9% of all
measured dots are labeled with an average of 1.1 streptavi-
din/dot (1 = σ+; 0.7 = σ−).
For PEG passivated arrays with larger TPP dots (i.e. 1 ×
105-2 × 105 nm2 dot surface area), 32 ± 11.6% of all TPP
dots carry 1.27 streptavidin complexes (1.2 = σ+; 0.91 =
σ−). When the substrate is passivated with lipids, a
much better total dot occupancy of 84 ± 22.4% is
achieved with 1.22 streptavidin molecules per labeled
dot (1.2 = σ+; 0.73 = σ−). The improved streptavidin
coverage of the dots on the lipid coated slides is notfully understood. An explanation may be the difference
in the thickness of the two passivation layers. The POPC
lipid bilayer has usually a thickness of 5–6 nm [35],
whereas 5000-PEG molecule form a ~27 nm (if fully
stretched [36]) high ‘mesh’ if exposed to an aqueous solu-
tion [28,37]. Hence, due to the adhesion of the PEG back-
bone to the nanodot, the PEG layer may screen a part of
the TPP nanodot surface from proteins [28,37].
For the largest TPP dot arrays of >2×105 nm2 surface
area, fabricated on a PEGylated surface, we observe that
70-93% of all dots are occupied with an average of 1.94
streptavidin molecules (1.6 = σ+; 1.1 = σ−). In case of the
lipid bilayer passivated substrate with >2×105 nm2 dot
surface area, 100% of all measured dots are loaded with
at least one streptavidin and 1.87 streptavidins (1.51 =
σ+; 1 = σ−) on average. In order to verify the influence of
the fluorophores on the streptavidin binding properties,
intermediately sized TPP dots with 1×105-2×105 nm2 area
are incubated with Alexa555-streptavidin. The Alexa555-
streptavidin incubated arrays, fabricated on PEGylated
slides, have 36 ± 7% of all dots loaded with at least one
streptavidin with an average of 1.2 streptavidin per loaded
dot (1.36 = σ+; 1 = σ−). In case of lipid passivated sub-
strates, 53 ± 13% of all dots are occupied by at least one
SA and these occupied dots carry 1.3 streptavidin mole-
cules on average (1.35 the upper error; 1 the lower error).
Binding of biotin
To prove whether the streptavidin is still biochemically
active, the TPP dots were incubated with a fluorophore–
biotin conjugate. For these experiments we used Atto655
labeled biotin and Alexa555 labeled streptavidin. Figure 1
depicts a section of a nanodot array with an average dot
surface area between 1×105 and 2×105 nm2, sequentially
incubated with Alexa555-streptavidin and Atto655-biotin
(Figure 1b, c). We determined an average binding of 0.7
biotin molecules per Alexa555-conjugated streptavidin.
Figure 4 Average nanodot Atto655-Streptavidin loads with respect to dot surface area. Above the graphs: The probability that a nanodot
carries at least one Atto655-SA. Graphs: Average number of Atto655-SA per nanodot, which carry at least one Atto655-SA for surface areas <2 × 104 nm2,
1 × 105-2 × 105 nm2 and > 2 × 105 nm2. Graphs a) and b) are for differently passivated substrates: a) lipid passivation, b) PEG passivation.
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bility is influenced by the adhesion to the nanodot, since a
native streptavidin possesses four biotin binding pockets
[21]. However, we find that on TPP dots with 200–
300 nm in diameter, statistically at least one biotin mol-
ecule is attached.
Discussion
STED-lithography and TPP offer the possibility of gener-
ating nanostructures, which allow a versatile protein
coating. Recently, we were able to show that STED-
lithographically fabricated polymer nanoanchors with
properly adjusted chemical properties have the ability to
bind a single antibody [15]. To extend the versatility of
the polymer structures, streptavidin has been used for
coating this time. Streptavidin is frequently used as a
coupling agent because of its high affinity to biotin
[21,23]. Nowadays, biotinylated macromolecules of al-
most any type are commercially available, rendering
streptavidin/biotin a well-suited system for polymer
functionalization.
Surprisingly, the adhesion of the streptavidin to the
polymer (80/20 SR499 and PETA mix) is significantly
weaker compared to antibody adhesion. Only ~10% of all
STED-lithographically prepared nanoanchors were occu-
pied by at least a single streptavidin as compared to 98%
in the case of antibodies [15]. The value is independent
from the substrate passivation either by PEG or lipids.
To achieve higher streptavidin loading, larger TPP fabri-
cated nanodots with surface areas <2 × 104 nm2, 1 × 105-2 ×
105 nm2 and >2 × 105 nm2 were tested. We observed that
on the nanodots with surface areas <2 × 104 nm2, 28 ± 9%
of all TPP nanodots on a lipid passivated substrate werecarrying 1.1 (1 = σ+; 0.7 = σ−) streptavidin on average and
40 ± 9% of the nanodots on a PEG passivated surface array
were occupied by 1 (1.3 = σ+; 0.96 = σ−) streptavidin on
average. For TPP dots with slightly larger surface areas of
1 × 105-2 × 105 nm2, the number of bound streptavidin
remained almost the same, 1.27 (1.2 = σ+; 0.91 = σ−) and
1.22 (1.2 = σ+; 0.73 = σ−) molecules per loaded nanodot
for PEG and lipid passivated slides, respectively. The occu-
pation efficiency of TPP nanodots changed significantly
for lipid passivated slides reaching 84 ± 22.4%, while on
PEG slides only 32 ± 11.6% of the dots were occupied. In
the case of the biggest structures >2×105 nm2, all TPP
dots on a lipid passivated arrays carry 1.87 streptavidin
(1.51 = σ+; 1.1 = σ−) on average. 70-93% of nanodot arrays
on PEGylated slides are occupied with 1.94 (1.6 = σ+;
1 = σ−) molecules/dot.
To test the biochemical activity of the streptavidin
complexes, the SA functionalized structures were incu-
bated with biotinylated fluorophores. We find that the
nanodot bound streptavidin still possesses biotin affinity,
although not all four binding pockets are accessible. On
average, 0.7 binding pockets per streptavidin are occu-
pied by a biotin molecule.
Conclusions
We demonstrated that almost a full coverage of TPP
fabricated nanodot arrays with one to two streptavidin
molecules can be achieved, despite the fact that the
streptavidin affinity to SR499/PETA acrylic nanodots is
lower than the affinity of antibodies. Furthermore, the
preserved biochemical activity of the streptavidin enables
a variety of biotinylated macromolecules to be attached.
A lower streptavidin adhesion to the polymers limits the
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areas >1 × 105 nm2 are required to facilitate a homogenous
streptavidin coating.
We have shown that TPP fabricated acrylate structures
can be functionalized with streptavidin, down to a single
molecule level. The straightforward method can be safely
applied to functionalize any arbitrarily shaped nano-
structure. The adhered streptavidins partially keep biotin
binding affinity. Single molecule fluorescence studies
proved that on average 0.7 biotin molecules were bound
to an attached streptavidin. Nanoscopic well-defined
structures capable of selective binding of any possible
protein via strepavidin-biotin coupling may find applica-
tion in in vitro sensing such as lab on chip devices with
a well-controlled surface area.
Methods
Passivation of glass slides with polyethyleneglycol (PEG)
PEG and lipid coated slides are used to minimize unspe-
cific protein adsorption on the glass surface. The PEG-
coated slides are passivated according to Pollheimer
et al. [38].
First, glass slides are cleaned with Piranha solution
(H2SO4/H2O2 (7:3)) and subsequently incubated for 20-
24 h with a reaction solution containing mPEG-Silane
(MW 5000) (Nanocs, New York, USA), anhydrous tolu-
ene (10 mg/ml) and 0.08% HCl. Subsequently, the slides
are rinsed with ethanol and acetone. The slides are
stored for a maximum of one week to exclude possible
aging processes of the PEG coated glass slides.
Passivation of glass slides with lipid bilayers
Palmitoyloleoylphosphatidylcholine (POPC) (Avanti
Polar Lipids Inc., Alabama, USA) - Lipid vesicles were
produced according to Huppa et al. [30] and kindly pro-
vided to us by the Institute of Applied Physics at the
Vienna University of Technology. After applying 100 μl
phosphate buffered saline (PBS) buffer to the chamber
of the lipid slides, 10 μl lipid is added for 15 minutes
allowing the lipid to coat the surface. Then, the sample
is rinsed with buffer to remove free lipid vesicles.
Labeling of streptavidin with Alexa555
Atto655 labeled streptavidin was purchased from Atto-
Tec GmbH (Siegen, Germany). Alexa 555 labeled SA
was prepared in our own lab as follows: Streptavidin was
labeled via N-hydroxysuccinimid (NHS)-ester conjugate
Alexa555 (Lifetechnologies, Vienna, Austria) according
to protocols provided by AttoTec GmbH (Siegen,
Germany). For the labeling, 30 μl of a 1 mg∕ml streptavi-
din (dissolved in PBS buffer) stock solution were ad-
justed to a pH of 8.6 with a 0.2-M sodium bicarbonate
buffer. A labeling ratio of 1:3 streptavidin to fluorophore
has been adjusted. The reaction mixture was incubatedfor 1 h at room temperature. The labeling solution was
purified via a PD-10 Sephadex® G-25 m (GE Healthcare,
Pittsburgh) purification column in PBS buffer. To con-
centrate the labeled streptavidin, the solution was trans-
ferred to a cut off filter (3–10.000 MWCO (Molecular
Weight Cut Off) PES) and centrifuged at 1200 rpm in a
centrifuge (Thermo, Multifuge 1S-R, HERAEUS, Thermo
Scientific, Vienna, Austria) until only 100–200 μl
remained. The concentrated solution was split into ali-
quots and stored at −20°C.
Incubation
PEG–coated slides were allowed to swell in PBS buffer
for 15 minutes to improve the surface passivation
against proteins and subsequently incubated with labeled
streptavidin for 5 minutes. We performed a stepwise in-
crease of the streptavidin amount (2 μL each) until the
nanodots were saturated (5 min/incubation-step). After
each incubation step, the chamber is rinsed with PBS to
remove unbound molecules. The same incubation pro-
cedure has been used for lipid coated slides.
Fluorescence analysis
In order to quantify the distribution of the fluorescence
strength of single streptavidin or the nano-anchors func-
tionalized with streptavidin, we applied an isotropic
undecimated wavelet transformation [33], used for the
recognition of individual fluorescent spots [34], com-
bined with Gaussian fitting for their parameterization
[39-41]. Similar analyses were performed for single
streptavidin proteins as well as for streptavidin coated
polymer dots. To quantify the number of molecules on
the dots, the fluorescence signal of each dot has been di-
vided by an average signal of fluorescent labeled strepta-
vidin. The average loading of the dots with streptavidin
molecules is then displayed in a histogram.
TPP/STED-lithography-setup
The two-photon polymerization starters are excited with
ultra-short laser pulses (82 MHz repetition rate, 110 fs,
780 nm, FFS-tSHG, Toptica, Gräfelfing, Germany) and
become locally depleted in the outer rim of the point
spread function by a depletion beam (532 nm, continu-
ous wave, Verdi-V5, Coherent, Santa Clara, CA, USA).
The 532 nm depletion beam was shaped into a donut
form using a 2π spiral phase mask (RPC Photonics,
Rochester, NY, USA) and a λ/4 plate converting the de-
pletion beam into a circularly polarized beam with a
handedness that matches the 2π spiral phase plate. A
combination of a two axes piezo stage (PI M686.D64,
Physikinstrumente, Karlsruhe, Germany) with 25 × 25
mm range, a position accuracy of 0.1 μm (0.3 μm repeat-
ability) on both axes and a three axes piezo stage (PI
562.3CD, Physikinstrumente, Karlsruhe, Germany) with
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(x/y/z-position repeatability of 2/2/4 nm) are used for
positioning. An avalanche photo diode (APD) is used for
detection of the backscattered light, enabling fine adjust-
ment of the relative focus positions. The setup is con-
trolled with a custom-made LabView®-based software.
Fluorescence-microscopy-setup
The images were taken on a modified Olympus IX81
(Olympus Austria GmbH Vienna, Austria) inverted micro-
scope. The samples were illuminated through an Olympus
UApo N 100× ∕ 1.49 NA oil objective lens (Olympus Austria
GmbH Vienna, Austria) with two diode lasers at 642 nm
(Omicron Laserage Laserprodukte GmbH—Phoxx® 642,
Rodgau-Dudenhofen, Germany), 532 nm (Cobolt Samba
100™, Solna, Sweden) and 491 nm wavelength (Cobolt
Calypso 100™, Solna, Sweden). The signal acquisition was
carried out on an Andor iXonEM + 897 (back-illuminated)
EMCCD (16-μm pixel size) (Andor Technology Ltd.,
Belfast, UK). The experiments were performed using excita-
tion powers of 0.126 kW∕cm2 and 0.025 kW∕cm2 at 642/
532 nm, respectively. The samples were illuminated for
10 ms (642/532 nm) with 40 ms delay time. A motor-
ized XY-stage is used for the sample movement (SCAN,
Märzhäuser Wetzlar GmbH & Co. KG, Wetzlar, Germany).
The illumination protocols were timed with a custom-
made LabView®-based control software.
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